Indian Hospitex Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 14-12-2024
- Paid Up Capital ₹ 1.50 Cr
as on 14-12-2024
- Company Age 21 Year, 3 Months
- Last Filing with ROC 31 Mar 2022
- Satisfied Charges ₹ 89.00 Cr
as on 14-12-2024
- Revenue 31.20%
(FY 2021)
- Profit 191.71%
(FY 2021)
- Ebitda -46.06%
(FY 2021)
- Net Worth 2.13%
(FY 2021)
- Total Assets -1.92%
(FY 2021)
About Indian Hospitex
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.50 Cr.
The company has closed loans amounting to ₹89.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Palepu Gopal and Narasaiah Arigela serve as directors at the Company.
- CIN/LLPIN
U40100TG2003PTC041637
- Company No.
041637
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Sep 2003
- Date of AGM
29 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Indian Hospitex?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Palepu Gopal | Director | 23-Jan-2023 | Current |
Narasaiah Arigela | Director | 24-Dec-2019 | Current |
Financial Performance and Corporate Structure Insights of Indian Hospitex.
Indian Hospitex Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 31.2% increase. The company also saw a substantial improvement in profitability, with a 191.71% increase in profit. The company's net worth moved up by a moderate rise of 2.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Indian Hospitex?
In 2021, Indian Hospitex had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Shanbalaji Pharma Distributors Private LimitedActive 2 years 7 months
Palepu Gopal is a mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 27 Nov 2017 | ₹40.00 Cr | Satisfied |
Axis Finance Limited Creation Date: 09 Oct 2015 | ₹35.00 Cr | Satisfied |
Hdfc Bank Limited Creation Date: 10 Jul 2012 | ₹14.00 Cr | Satisfied |
How Many Employees Work at Indian Hospitex?
Indian Hospitex has a workforce of 14 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Indian Hospitex, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indian Hospitex's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.